Company creation is one of the value creation routes for work obtained from academic or clinical research.  It should always be seen in the perspective of other possible approaches, with a view to optimisation for co-owners and inventors and the success of economic and societal value creation.

Amongst the fundamental issues around company creation, it is essential to understand that “creating a company” is first, and above all, a human adventure which involves you personally in the long term.  It is a complex, demanding and occasionally destabilising path, but one which is also extremely exciting and intellectually enriching.

Inserm Transfert supports the creation of companies with a high ambition for development.  It requires the combination of 6 factors for success

  • a solid team ready to work together in the long term; 
  • a distinguished innovation (technology or product) validated by robust pre/maturation against the “due diligence” standards of companies or investors;
  • solid intellectual protection;
  • a market access strategy which is clearly defined and realistic;
  • a proven development plan;
  • a realistic and coherent funding plan.

Inserm Transfert offers pre-entrepreneurship support as soon as a researcher or inventor seeks to become involved in entrepreneurship, occasionally before the very existence of the related technological project.  The company sets up a supporting pathway for thinking by the researcher/inventor which is based on the complementarities of its partners in company creation (incubators, investors, etc.). 

This email address is being protected from spambots. You need JavaScript enabled to view it. for more information.